πŸ‡ΊπŸ‡Έ FDA
Patent

US 9505719

Synthesis and use of kinase inhibitors

granted A61PA61P19/02A61P29/00

Quick answer

US patent 9505719 (Synthesis and use of kinase inhibitors) held by VERASTEM, INC. expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VERASTEM, INC.
Grant date
Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P19/02, A61P29/00, A61P37/00, A61P43/00